6 - 12 July 2019
These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Poor experiences require national plan for neurology
People in England with neurological conditions are facing long waiting times, poor access to specialists and a lack of personalised care, according to a report/survey by the Neurological Alliance. They call for a National Plan for Neurology and suggest people write to their MPs
Source: Neurological Alliance
MS Trust link: Call for national neurology plan following largest ever survey of people with neurological conditions - MS Trust news item
Regular standing helps symptoms
Opicinumab trial unsuccessful
A trial comparing people taking Avonex (interferon beta 1a) with or without opicinumab (anti-LINGO-1) failed to show an effect on walking and upper limb coordination. Another study, already fully recruited, is starting focussing on people within 20 years of onset - a subgroup who seemed to do best in the original trial.
Source: National MS Society (USA)
MS Trust link: Drugs in development
MS in the Media
27 Nov 2020 - 00:00
- Depression affects multitasking in MS
- Benefits process in Scotland
- Cancer risks and multiple sclerosis
- Gut immune cells and relapses
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.